院前现场麻醉医师处理重型创伤性脑损伤患者与更低死亡率和更好神经功能结局相关
该研究纳入2005—2010年及2012—2015年两个研究地点、从事故现场直接转运至大学医院的重型TBI(GCS≤8)孤立性颅脑损伤患者。主要终点为死亡率(651例),次要终点为6个月改良GOS神经功能结局(634例),采用二元logistic回归分析。结果显示,现场无麻醉医师与更高死亡率相关(OR 1.89,95%CI 1.20-2.94),低血压亦与更高死亡率相关(OR 3.92,95%CI 1.08-14.23);现场有麻醉医师与良好神经功能结局相关(OR 1.75,95%CI 1.09-2.80)。作者结论认为院前现场麻醉医师处理重型TBI与更低死亡率和更好神经功能结局相关。
要点
- 现场无麻醉医师与重型TBI患者更高死亡率相关(OR 1.89,95%CI 1.20-2.94)。
- 现场有麻醉医师与重型TBI患者良好6个月神经功能结局相关(OR 1.75,95%CI 1.09-2.80)。
- 现场低血压与更高死亡率相关(OR 3.92,95%CI 1.08-14.23),且与不良神经功能结局相关(OR 0.19,95%CI 0.04-0.82)。
- 年龄越高死亡率越高(OR 1.06,95%CI 1.05-1.07),现场GCS越低死亡率越高(OR 0.85,95%CI 0.79-0.92)。
- 年龄越低(OR 0.95,95%CI 0.94-0.96)、现场GCS越高(OR 1.21,95%CI 1.20-1.30)与良好神经功能结局相关。
适用人群与场景
- 重型TBI患者,定义为头部损伤导致格拉斯哥昏迷评分(GCS)≤8。
- 孤立性TBI患者,从事故现场直接转运至大学医院者纳入。
- 研究数据来自2005—2010年和2012—2015年两个研究地点。
诊断标准与关键阈值
- 重型TBI定义:头部损伤导致GCS≤8。
- 神经功能结局采用改良6个月格拉斯哥结局评分(GOS):死亡、不良结局(GOS 2-3)、良好结局(GOS 4-5)。
红旗征与不能漏的情况
- 现场低血压与更高死亡率相关(OR 3.92,95%CI 1.08-14.23),且与不良神经功能结局相关(OR 0.19,95%CI 0.04-0.82)。
- 现场缺氧作为可用的预后变量被纳入分析。
研究设计与关键结果
- 研究类型为回顾性分析,纳入2005—2010年及2012—2015年两个研究地点、从事故现场直接转运至大学医院的重型TBI(GCS≤8)孤立性颅脑损伤患者。
- 死亡率数据651例,神经功能结局数据634例。
- 主要分析:更高年龄(OR 1.06,95%CI 1.05-1.07)、更低现场GCS(OR 0.85,95%CI 0.79-0.92)、无现场麻醉医师(OR 1.89,95%CI 1.20-2.94)及低血压(OR 3.92,95%CI 1.08-14.23)与更高死亡率相关。
- 次要分析:更低年龄(OR 0.95,95%CI 0.94-0.96)、更高现场GCS(OR 1.21,95%CI 1.20-1.30)及有现场麻醉医师(OR 1.75,95%CI 1.09-2.80)与良好神经功能结局相关;低血压(OR 0.19,95%CI 0.04-0.82)与不良结局相关。
证据类型、等级与局限
- 研究类型:回顾性分析,数据来自两个研究地点2005—2010年及2012—2015年。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,院前现场麻醉医师处理重型TBI患者与更低死亡率和更好神经功能结局相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with isolated traumatic brain injury (TBI) are likely to benefit from effective prehospital care to prevent secondary brain injury. Only a few studies have focused on the impact of advanced interventions in TBI patients by prehospital physicians. The primary end-point of this study was to assess the possible effect of an on-scene anaesthetist on mortality of TBI patients. A secondary end-point was the neurological outcome of these patients.
METHODS: Patients with severe TBI (defined as a head injury resulting in a Glasgow Coma Score of ≤8) from 2005 to 2010 and 2012-2015 in two study locations were determined. Isolated TBI patients transported directly from the accident scene to the university hospital were included. A modified six-month Glasgow Outcome Score (GOS) was defined as death, unfavourable outcome (GOS 2-3) and favourable outcome (GOS 4-5) and used to assess the neurological outcomes. Binary logistic regression analysis was used to predict mortality and good neurological outcome. The following prognostic variables for TBI were available in the prehospital setting: age, on-scene GCS, hypoxia and hypotension. As per the hypothesis that treatment provided by an on-scene anaesthetist would be beneficial to TBI outcomes, physician was added as a potential predictive factor with regard to the prognosis.
RESULTS: The mortality data for 651 patients and neurological outcome data for 634 patients were available for primary and secondary analysis. In the primary analysis higher age (OR 1.06 CI 1.05-1.07), lower on-scene GCS (OR 0.85 CI 0.79-0.92) and the unavailability of an on-scene anaesthetist (OR 1.89 CI 1.20-2.94) were associated with higher mortality together with hypotension (OR 3.92 CI 1.08-14.23). In the secondary analysis lower age (OR 0.95 CI 0.94-0.96), a higher on-scene GCS (OR 1.21 CI 1.20-1.30) and the presence of an on-scene anaesthetist (OR 1.75 CI 1.09-2.80) were demonstrated to be associated with good patient outcomes while hypotension (OR 0.19 CI 0.04-0.82) was associated with poor outcome.
CONCLUSION: Prehospital on-scene anaesthetist treating severe TBI patients is associated with lower mortality and better neurological outcome.
参考来源
- Pakkanen T, Nurmi J, Huhtala H, et al. Prehospital on-scene anaesthetist treating severe traumatic brain injury patients is associated with lower mortality and better neurological outcome. Scand J Trauma Resusc Emerg Med. 2019. PMID: 30691530. doi:10.1186/s13049-019-0590-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。